![](https://www.worldpharmatoday.com/images/nBanners/Docuvera-728x90.jpeg")
Revenue of first quarter 2012
ADOCIA, a biotechnology company specialized in the development of best-in-class medicines with already-approved therapeutic proteins,...
Pfizer reports fourth-quarter and full-year 2011 results
Pfizer Inc. reported financial results for fourth-quarter and full-year 2011. Fourth-quarter 2011 revenues were $16.7 billion,...
NxStage® to Report Fourth Quarter and Full Year 2011 Financial Results
NxStage Medical, Inc. (Nasdaq: NXTM), a leading manufacturer of innovative dialysis products, today announced...
Cubist Pharmaceuticals Reports 2011 Fourth Quarter and Full Year Financial Results
Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced results for the fourth quarter and year...
Stable consolidated revenues, costs and losses for Hybrigenics
Hybrigenics (ALHYG), a bio-pharmaceutical company listed on Alternext (NYSE-Euronext) in Paris, with a focus...
Hikma Pharma Q1 revenue rises
Hikma Pharmaceuticals, a manufacturer of a range of both branded and non-branded generic and inlicensed...
Furiex Pharmaceuticals Enters into Loan Agreement for up to $15 Million Furiex Pharmaceuticals Inc.
Furiex Pharmaceuticals, Inc. announced it has entered into a loan agreement with MidCap Financial and...
China Shenghuo Q2 sales climb 58%
China Shenghuo, engaged in the research, development, manufacture and marketing of Sanchi-based medicinal and pharmaceutical,...
Vivus reports Qnexa phase 3 study results
Vivus, a developer of therapies to address obesity, sleep apnea, diabetes and male sexual health,...
Novartis delivers strong financial results and four major approvals
Novartis' net sales rose 27% (+19% cc) to USD 14.9 billion. Currency benefited sales by...